Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase 0 Trials for DB01008 (Busulfan)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01959477Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell TransplantTreatment